ICU Medical (ICUI) Tops Q4 EPS by 20c, provides guidance

ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.91, $0.20 better than the analyst estimate of $1.71. Revenue for the quarter came in at $540.7 million versus the consensus estimate of $532.18 million.

GUIDANCE:

ICU Medical sees FY2026 EPS of $7.75-$8.45, versus the consensus of $8.01.

Company estimates GAAP net income to be in the range of $26 million to $44 million and GAAP net earnings per share estimated to be in the range of $1.03 to $1.74.

Company expects adjusted EBITDA to be in the range of $400 million to $430 million

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• S&P Global (SPGI) Declares $0.97 Quarterly Dividend; 1% Yield
• A.O. Smith executive chairman to retire, CEO to assume chairman role